Navigation Links
Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc.
Date:1/15/2014

companies and could cause actual results to differ materially from those expressed in forward-looking statements contained in this press release. These factors include, but are not limited to: the risk that the acquisition will not close when expected or at all; the risk that Valeant's business and/or Solta's business will be adversely impacted during the pendency of the acquisition; the risk that the operations of the two companies will not be integrated successfully; and other risks and uncertainties, including those detailed from time to time in the companies' periodic reports filed with the Securities and Exchange Commission ("SEC") and in the case of Valeant, the Canadian Securities Administrators ("CSA"), including current reports on Form 8-K, quarterly reports on Form 10-Q and annual reports on Form 10-K, which have been filed with the SEC and in the case of Valeant, the CSA.  The forward-looking statements in this press release are qualified by these risk factors. The companies assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

Additional Information and Where to Find It

This press release is neither an offer to purchase nor a solicitation of an offer to sell shares of Solta. Valeant filed a Tender Offer Statement on Schedule TO with the SEC on December 23, 2013. Solta filed a Solicitation/Recommendation Statement on Schedule 14D-9 with respect to the offer on December 23, 2013.   Stockholders of Solta are urged to read the tender offer materials (including the Offer to Purchase, a related Letter of Transmittal and certain other offer documents) and the Solicitation/Recommendation Statement, in each case as amended (to the extent applicable), because they contain important information which should be read carefully before any decision is made with respect to the tender offer. The Offer to Purchase, the related Letter of Transmittal and
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Presentation Schedules, Stock Movements, Agreements, and New Appointments - Research Report on Celgene, Merck, Bristol-Myers, Valeant, and Mylan
2. Valeant Pharmaceuticals To Present At Industry Conferences
3. Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
4. Valeant Pharmaceuticals Announces Redemption Of The Remaining $465.5 Million Aggrerate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016
5. Valeant Pharmaceuticals Announces Pricing Of Private Offering Of Senior Notes
6. Valeant Pharmaceuticals Announced Redemption Of $450 Million Aggregate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016
7. Valeant Pharmaceuticals Reports 2013 Third Quarter Financial Results
8. Valeant Pharmaceuticals Announces Settlement Agreement With Anacor
9. Valeant Pharmaceuticals Announces Partnership With National Coalition Against Domestic Violence
10. Valeant Pharmaceuticals Announces Continuance
11. Valeant Pharmaceuticals Reports 2013 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , July 1, 2015 ContraVir Pharmaceuticals, ... on the development and commercialization of targeted antiviral therapies, ... Fitzgerald Inaugural Healthcare Conference taking place in ... at Le Parker Meridien Hotel. ... overview of the Company,s business during his live presentation ...
(Date:7/1/2015)... Pa. , July 1, 2015 Precyse, ... and education, announced today that, as part of its ... an agreement to be acquired by investment firm Pamplona ... private equity investors, Altaris Capital Partners and NewSpring Capital, ... in 1999, has assisted nearly 5,000 healthcare facilities and ...
(Date:7/1/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/46q6x8/2015_strategies ... "2015 Strategies in the Home/Self Testing Market" ... 175-page report provides analysis of the major home/self ... pregnancy, ovulation, and occult blood. The report presents ... competitive profiles. The growing economic pressures ...
Breaking Medicine Technology:ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference 2Precyse Enters into Acquisition Agreement with Pamplona Capital Management 2Precyse Enters into Acquisition Agreement with Pamplona Capital Management 32015 Strategies in the Home/Self Testing Market 2
... - Phase II Data Indicate Overall and Disease-Free ... Results from an adjuvant trial in,high-risk melanoma patients ... (sargramostim) achieved disease-free and/or overall,survival. These findings, which ... at the 44th annual meeting of the American ...
... SUNNYVALE, Calif., June 5 Pharmacyclics, Inc.,(Nasdaq: ... from a Phase 1/2 study showing a,46 ... multiply recurrent,non-Hodgkin,s lymphoma (NHL) who were treated ... Yttrium-90 Ibritumomab Tiuxetan,(Zevalin(TM)), an approved antibody-targeted radiation ...
Cached Medicine Technology:Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients 2Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients 3Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients 4Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients 5Phase 1/2 Trial of Motexafin Gadolinium Plus Antibody Targeted Radiation Therapy Demonstrates High Complete Response Rate in Patients With Non-Hodgkin's Lymphoma 2Phase 1/2 Trial of Motexafin Gadolinium Plus Antibody Targeted Radiation Therapy Demonstrates High Complete Response Rate in Patients With Non-Hodgkin's Lymphoma 3Phase 1/2 Trial of Motexafin Gadolinium Plus Antibody Targeted Radiation Therapy Demonstrates High Complete Response Rate in Patients With Non-Hodgkin's Lymphoma 4
(Date:7/1/2015)... ... July 01, 2015 , ... The Collaborative for Children and ... Community Trust. The grant will allow CCF to improve quality of care and save ... was formed to respond to many changes in New York’s Medicaid system. Experts agree ...
(Date:7/1/2015)... ... 2015 , ... Summer recess has a whole new meaning. Thanks to social ... plastic surgery when they’re looking for a boost in self-esteem. According to the American ... on patients ages 19 and younger in 2012, an increase from previous years. ...
(Date:7/1/2015)... ... 2015 , ... The 28th annual Charity Horse Show hosted by the Mid-South ... 6 p.m. in Pugh Bourne Park, 343 Oakfield Road. The event will again benefit ... Elvis impersonator, a silent auction and concessions. , Horses and riders from around the ...
(Date:7/1/2015)... ... , ... Convoy of Hope will partner with local businesses, churches, ... August 1, at Spring Lake Park High School. , During the celebration, Convoy of ... of goods and services including free food, health services, family portraits, job services, a ...
(Date:7/1/2015)... ... July 01, 2015 , ... RowdMap Inc. ... newly released white paper: “Pro-actively Identifying the High-Cost Patient Population: Insights from the ... is available at: http://www.hcttf.org/resouces-tools . , The Healthcare Transformation Task Force is ...
Breaking Medicine News(10 mins):Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3Health News:Top Manhattan Facial Plastic Surgeon Dr. Sam Rizk Comments on Teen Surgery Trends 2Health News:Top Manhattan Facial Plastic Surgeon Dr. Sam Rizk Comments on Teen Surgery Trends 3Health News:Convoy of Hope Hosts Community Event in the Twin Cities 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3
... ... local farm to table produce, acclaimed chefs from all over the Los ... oldest and most respected certified farmers’ market in California: the Downtown ... than 4 city blocks. Two of those chefs who regularly buy their ...
... treatment and weight gain, researchers say , WEDNESDAY, June ... disorder anorexia nervosa can actually lose brain volume, but ... can regain the gray matter that they lost from ... different parts of the body, including the brain," study ...
... In 2008 the Nuclear Science Division (NSD) of the ... the Applied Nuclear Physics program, headed by NSD,s Kai ... with Lawrence Livermore National Laboratory. One of the goals ... and equipment created for basic research and develop them ...
... ... ... Florida Department of Health (DOH) today announced the launch of its newly ... to complement the We Make the Change program, a statewide media campaign designed to ...
... 2010 With the mutual goal of improving ... Convention (USP) and the Ukraine Scientific Pharmacopoeial Centre ... entered into an agreement to share standards for ... Specifically, the Centre will have a five-year, renewable ...
... Chronically ill children with private insurance are much less ... to be admitted to a California hospital offering specialized ... at Lucile Packard Children,s Hospital and the Stanford University ... the likelihood of a chronically ill child being admitted ...
Cached Medicine News:Health News:Shop like Celebrity Chefs at Downtown Santa Monica Farmers' Market. Easy Summer Recipes Incorporate Fresh Ingredients from the Farmers' Market 2Health News:Shop like Celebrity Chefs at Downtown Santa Monica Farmers' Market. Easy Summer Recipes Incorporate Fresh Ingredients from the Farmers' Market 3Health News:Shop like Celebrity Chefs at Downtown Santa Monica Farmers' Market. Easy Summer Recipes Incorporate Fresh Ingredients from the Farmers' Market 4Health News:Brain Volume Lost to Anorexia Reversible 2Health News:Applied nuclear physics for biomedicine, nuclear security and basic science 2Health News:Applied nuclear physics for biomedicine, nuclear security and basic science 3Health News:Applied nuclear physics for biomedicine, nuclear security and basic science 4Health News:Applied nuclear physics for biomedicine, nuclear security and basic science 5Health News:Applied nuclear physics for biomedicine, nuclear security and basic science 6Health News:Applied nuclear physics for biomedicine, nuclear security and basic science 7Health News:Florida Department of Health Launches Redesigned Website for HIV Campaign 2Health News:US, Ukraine agree to share standards for quality of medicines 2Health News:Stanford/Packard study finds surprising disparity in where chronically ill kids hospitalized 2Health News:Stanford/Packard study finds surprising disparity in where chronically ill kids hospitalized 3Health News:Stanford/Packard study finds surprising disparity in where chronically ill kids hospitalized 4
Provides outstanding patient warming and safety throughout the hospital and is nearly half the size and one-third the weight of earlier units....
The SnuggleWarm Convective Warming provides the technology and the tools to effectively enhance the quality of patient care....
The product, which is comprised of a non-intrusive panty-liner, offers a simple to use classification tool that uses color identification for interpretation of the results....
The Affirm™ VPIII tests RNA probe technology offers a dependable, rapid means toward early identification and treatment of patients suffering from these pathogens....
Medicine Products: